Latin America

Overview

ASOP Global began a Latin America initiative, with an initial focus on Mexico and Brazil during 2018. Attached are portions of the ASOP Global website translated into Spanish and Portuguese.

ASOP Global will collaborate with Latin American partners to expand awareness and protections with respect to the dangers of substandard and falsified (S&F) medicines both from unregulated online pharmacies and brick-and-mortar outlets including botanicas, bodegas, pulperías, and flea markets.

ASOP Global will initially focus its Latin America Initiative on Mexico and Brazil, with anticipated future expansion to other Latin American countries. ASOP Global will make an initial trip to Mexico and Brazil during September 2018 to meet with Mexico and Brazil industry associations, US Embassy staff, USFDA, potential partners and stakeholders.

ASOP Global will organize a delegation trip to Mexico and Brazil during early 2019 for follow-up activities and meetings with new Mexico and Brazil government officials. The early 2019 trip will be timed to take place after the upcoming Mexico and Brazil elections for meeting with new government officials in COFEPRIS (Mexico) and ANVISA (Brazil).

ASOP Global will also compile data on the sale and distribution of falsified and substandard medicines by key on-line and off-line marketplaces in Latin America, develop fact sheets and educational materials for patients in Spanish and Portuguese, and develop a new Latin America page, with translation into Spanish and Portuguese, for the ASOP Global website.